Brief: Keros Therapeutics Announces Leadership Updates
17/06/2024 23:31
June 17 (Reuters) - Keros Therapeutics Inc KROS.O :
* KEROS THERAPEUTICS ANNOUNCES LEADERSHIP UPDATES
* KEROS THERAPEUTICS INC - APPOINTED JASBIR S. SEEHRA,
PH.D.,
CHIEF EXECUTIVE OFFICER, AS CHAIR OF BOARD, EFFECTIVE JULY 1,
2024.
* KEROS THERAPEUTICS INC: CHRISTOPHER ROVALDI HAS BEEN
PROMOTED TO
PRESIDENT, EFFECTIVE JULY 1, 2024
Source text for Eikon: ID:nGNX7ntVyw
Further company coverage: KROS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Keros Therapeutics
See all newsBrief: Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing
Keros Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Keros Therapeutics Q2 net loss narrows on lower expenses
Brief: Keros Therapeutics - Keith Regnante Resigns As CFO
Keros Therapeutics posts Q1 net loss as license revenue drops